2026-04-17T07:45:18Zhttps://recercat.cat/oai/requestoai:recercat.cat:2445/1716892025-12-05T12:19:39Zcom_2072_1057col_2072_478916col_2072_478917
RECERCAT
author
Casanovas i Casanovas, Oriol
2020-11-02T09:44:09Z2020-11-02T09:44:09Z2012-04-012020-10-29T15:04:25Z
Anti-angiogenic drugs, used for cancer treatment, target blood-vessel formation in tumours. Two studies commented here show that such drugs can reduce the efficiency of other anticancer agents and increase the aggressiveness of tumours.
(c) Springer Science and Business Media LLC, 2012 info:eu-repo/semantics/openAccess
Angiogènesi
Medicaments antineoplàstics
Tumors
Neovascularization
Antineoplastic agents
Cancer: Limitations of therapies exposed
info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion